These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28635114)

  • 21. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
    Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
    J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.
    Mothapo KM; Ten Oever J; Koopmans P; Stelma FF; Burm S; Bajramovic J; Verbeek MM; Rikkert MGO; Netea MG; Koopman G; van der Ven AJ
    J Neurovirol; 2017 Apr; 23(2):250-259. PubMed ID: 27882497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA and neutral lipid contents of peripheral cells as predictive biomarkers of mild cognitive impairment and Alzheimer's disease: Highlights on the interest of a cytomic approach for the characterization of dementia.
    Zarrouk A; Lizard G
    Cytometry A; 2015 Jan; 87(1):3-4. PubMed ID: 25263350
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral markers of oxidative stress in probable Alzheimer patients.
    Repetto MG; Reides CG; Evelson P; Kohan S; de Lustig ES; Llesuy SF
    Eur J Clin Invest; 1999 Jul; 29(7):643-9. PubMed ID: 10411672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of the Quality of Life-Alzheimer's Disease Scale for mild cognitive impairment.
    Tatsumi H; Yamamoto M; Nakaaki S; Hadano K; Narumoto J
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):533. PubMed ID: 21851464
    [No Abstract]   [Full Text] [Related]  

  • 28. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
    Hare DJ; Faux NG; Roberts BR; Volitakis I; Martins RN; Bush AI
    Metallomics; 2016 Jun; 8(6):628-32. PubMed ID: 26962965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
    Nilsson K; Gustafson L; Hultberg B
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):666-72. PubMed ID: 15254923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
    J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood test can predict Alzheimer's disease, say US scientists.
    Wise J
    BMJ; 2014 Mar; 348():g2074. PubMed ID: 24620352
    [No Abstract]   [Full Text] [Related]  

  • 33. A Novel Plasma Based Biomarker of Alzheimer's Disease.
    Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
    J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
    J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homeostasis of metals in the progression of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Biometals; 2014 Jun; 27(3):539-49. PubMed ID: 24668390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
    Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
    J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease.
    Rammouz G; Lecanu L; Aisen P; Papadopoulos V
    J Alzheimers Dis; 2011; 24 Suppl 2():5-16. PubMed ID: 21335661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.